Analysis of Outpatient Type 2 Diabetes Mellitus Treatment Patterns: A Four-Criteria Framework at Sanjiwani Hospital, Gianyar
DOI:
https://doi.org/10.71341/bmwj.v1i2.19Keywords:
diabetes mellitus, rational drug use, prescription practicesAbstract
Background: Diabetes mellitus is a chronic condition with high blood sugar levels caused by insufficient insulin production. Improper prescribing can lead to ineffective treatment, increased health risks, and resource wastage.
Objective: This study aims to assess compliance with four essential criteria for rational drug use in treating Type 2 Diabetes Mellitus (DM2) patients at Sanjiwani Hospital in Gianyar. By examining these areas, the study seeks to identify opportunities for improving DM2 treatment and ensuring that practices align with established standards to enhance patient outcomes and safety.
Methods: A cross-sectional survey was conducted from May to June 2024, analyzing purposively collected prescriptions. A total of 113 prescriptions were reviewed to assess prescribing practices.
Results: The study evaluated prescribing accuracy based on four criteria: drug selection, dosage, indication, and timing. Results showed 100% accuracy in drug selection and indication, 76.1% accuracy in dosage, and 78.8% accuracy in timing.
Conclusion: These findings suggest that medication practices at Sanjiwani Hospital for DM2 patients are generally satisfactory. However, pharmacists should play an active role in providing pharmaceutical information and counseling to achieve the best clinical outcomes. This includes ensuring correct dosage and timing to improve overall treatment effectiveness and patient safety.
References
Bardoczi, J. B., & Aubert, C. E. (2024). Optimization of type 2 diabetes care in adults aged 65 or older. Canadian Family Physician, 70(6), 391–394. https://doi.org/DOI: 10.46747/cfp.7006391
Destiyani, Nisa, N. A., Zaila M.A, T., & Agus Santoso, A. P. (2022). Gambaran tingkat kepuasan pasien terhadap kualitas pelayanan obat di Apotek Kinan Farma Mojosongko periode November-Desember tahun 2021. Media Farmasi Indonesia, 17(1). https://doi.org/10.53359/mfi.v17i1.189
Dwi Agung Jaka Perdana, & Nofita. (2021). Evaluasi penggunaan obat antihipertensi pada pasien DM tipe-2. Journal Pharmacy and Tropical Issues, 1(3), 61–67. https://doi.org/DOI: https://doi.org/10.56922/pti.v1i03.166
Fajar, D. R., Stevani, H., & Kamaruddin. (2020). The Diabetes mellitus treatment patterns in geriatric patients in inpatient installation of Tk. II Pelamonia Hospital at Makassar. Media Farmasi, XVI(1), 42–48. https://doi.org/10.32382/mf.v16i1.1475
Padhi, S., Kumar, A., & Behera, A. (2020). Type II diabetes mellitus: a review on recent drug based therapeutics. Biomedicine & Pharmacotherapy, November 1(131), 110708. https://doi.org/10.1016/j.biopha.2020.110708
PERKENI. (2021). Pedoman dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2021. PB. Perkeni.
Pinakesty, A., & Azizah, R. N. (2020). Correlation between lipid profile with type 2 Diabetes mellitus progression. Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 8(2), 66–72. https://doi.org/10.53366/jimki.v8i2.131
Rashidi, A., Tahir, M., Agussaiful, N., Hisham, S. A., Abdul, A., Yahaya, A. Y., & Devaraj, N. K. (2020). Drug utilisation evaluation study on patients with Diabetes mellitus among Rohingya refugees in IMARET mobile clinic. Malaysian Journal of Medicine and Health Sciences, 16(September 2015), 51–57.
Rietz, M., Lehr, A., Mino, E., Lang, A., Szczerba, E., Schiemann, T., Herder, C., Saatmann, N., Geidl, W., & Barbaresko, J. (2022). Physical activity and risk of major diabetes-related complications in individuals with diabetes: A systematic review and meta-analysis of observational studies. Diabetes Care, 45(December), 3101–3111. https://doi.org/https://doi.org/10.2337/dc22-0886
Rosita, R., Kusumaningtiar, D. A., Irfandi, A., & Ayu, I. M. (2022). Hubungan antara jenis kelamin, umur, dan aktivitas fisik dengan Diabetes melitus tipe 2 pada lansia di Puskesmas Balaraja Kabupaten Tangerang. Jurnal Kesehatan Masyarakat (Undip), 10(3), 364–371. https://doi.org/10.14710/jkm.v10i3.33186
Rukminingsih, F. (2021). Penggunaan insulin pada pasien Diabetes melitus tipe 2 peserta JKN di Instalasi Farmasi Rawat Jalan Rumah Sakit St. Elisabeth Semarang. Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi Dan Kesehatan, 6(1), 79–86. https://doi.org/10.36387/jiis.v6i1.611
Saptayuda, M. F., & Yuniarsih, N. (2023). Analisis kepuasan pasien BPJS terhadap pelayanan farmasi pada peserta program rujuk balik di Apotek Kimia Farma Karawang. Jurnal Buana Farma, 3(1), 23–26. https://doi.org/10.36805/jbf.v3i1.777
Singh, A. K., Singh, R., & Chakraborty, P. P. (2021). Diabetes monotherapies versus Metformin-based combination therapy for the treatment of type 2 diabetes. International Journal of General Medicine, 3833–3848. https://doi.org/10.2147/IJGM.S295459
Suryanita, M. A. (2020). Pola peresepan obat anti Diabetes Mellitus tipe II pada pasien geriatri. Journal of Pharmaceutical Science and Herbal Tecnology, 5(1), 23–27.
Suryanti, S. (2021). Hubungan gaya hidup dan pola makan dengan kejadian Diabetes mellitus di Rumah Sakit Bhayangkara Kota Makassar. Jurnal Promotif Preventif, 4(1), 1–9. https://doi.org/10.47650/jpp.v4i1.246
Tananda, M. F., Widowati, I. G. A. R., Paramurhi, I. A. P., & Dhiancinantyan Windydaca Brata Putri. (2023). Ketepatan peresepan pasien Diabetes melitus type-2 di Puskesmas Buleleng II. Bali Health Published Journal, 5(2), 51–58. https://doi.org/https://doi.org/10.47859/bhpj.v5i2.419
Triastawan, I. K. A., Widowati, I. G. A. R., Tunas, I. K., & Dhiancinantyan Windydaca Brata Putri. (2024). Kewaspadaan diri dan kepatuhan pasien Diabetes mellitus tipe 2 di Puskesmas IV Denpasar Selatan. Lumbung Farmasi, 5(1), 31–36. https://doi.org/DOI: https://doi.org/10.31764/lf.v5i1.17054
Wafa, W., Septini, R., & Sauriasari, R. (2022). Comparison of Metformin-sulfonylurea and Metformin-acarbose combination therapies on glycemic outcomes: A retrospective cohort study. Current Diabetes Reviews, 18(7), 86–92. https://doi.org/10.2174/1573399818666211103161917
Xie, X., Wu, C., Hao, Y., Wang, T., Yang, Y., Cai, P., Zhang, Y., Huang, J., Deng, K., Yan, D., & Lin, H. (2023). Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. Frontiers in Endocrinology, 14(December), 1–17. https://doi.org/10.3389/fendo.2023.1301093
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 I Gusti Ayu Rai Widowati, Kadek Ari Teja Kusuma, Dewa Ayu Putu Satrya Dewi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License
This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercial purposes.
- Adaptation — mixing, changing, and developing materials for any purpose, even commercial ones.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
